In patients with Type 1 diabetes, having correct glucose levels is the first step in high quality care. A recent study, published in Diabetes Care, tested the effectiveness in continuous glucose monitoring (CGM) with and without blood glucose monitoring (BGM) measurement.

The clinical trial included participants from 14 different sites within the Type 1 diabetes Exchange Clinic Network. Participants were over 18 years old, have Type 1 diabetes, used an insulin pump and have a blood glucose level less than nine percent. The 26-week trial split participants into a CGM only group and CGM with BGM measurements.

Results showed that CGM use did not differ with or without BGM measurements. “Use of CGM without regular use of confirmatory BGM is as safe and effective as using CGM with BGM in well-controlled adults with T1D at low risk for severe hypoglycemia,” concluded first author on the study, Grazia Aleppo and colleagues.